X
  • Number
  • FLOSEP-C-019P

Introduction

This product can easily and quickly separate high purity CD19+B cells from fresh or frozen peripheral blood mononuclear cells. The total number of cells that can be treated is 1x10^9, and after purification, more than 90% of CD19+B cells can be obtained, providing a powerful tool for the use of CD19+B cells in basic and clinical research.

Advantage

Easy to operate, only a magnetic pole/cell screen is required to complete the entire operation
Fast operation, only 40 minutes to complete the entire separation operation
Objective The purity of CD19+B cells is high, the purity of CD19+B cells can be more than 90%
More than 90% CD19+B cells could be extracted from PBMC
High quality raw materials, the materials used are sterile, mycoplasma free, low endotoxin

Details Document